Some have predicted that the Xience will quickly snag more than 20% of the market, while the Promus may grab an additional 20%, so that together the two stents will represent the bulk of US usage.

Xience, and a version of the device called Promus sold by Boston Scientific, are currently used in 54 percent of U.S. procedures to implant the drug-coated stents, said Michael Weinstein ...

The Xience V stent is manufactured by Abbott, the sponsor of this study, but is also licensed for distribution by Boston Scientific, under the name "Promus." As previously reported by heartwire ...

One-year results of the NEXT (Nobori biolimus-eluting versus Xience/Promus everolimus-eluting Stent) trial were initially presented at the ACC/i2 Scientific Session in San Francisco, CA, in March 2013 ...

A large new meta-analysis published in the Lancet provides the best evidence yet that the cobalt-chromium everolimus eluting (CoCr-EES) stents (Xience and Promus) have a significantly lower ...

The stent, which was originally developed by Guidant Corp., is also marketed by Boston Scientific under the name Promus. Abbott acquired the rights to Xience in a side deal with Boston Scientific ...

Both stent systemswould be covered by the same FDA approval. The PROMUS and XIENCE V stent systems are investigational devices in theU.S. and not yet approved for sale. PROMUS is a private-labeled ...

The PROMUS Stentis a private-labeled XIENCE(TM) V Everolimus-Eluting Coronary Stent Systemmanufactured by Abbott and distributed by Boston Scientific under an agreementexecuted prior to the 2006 ...

The PLATINUM Workhorse Trial compared the PROMUS Element(TM) Stent (Platinum Chromium Everolimus-Eluting stent) to the Xience V(TM) Stent (Cobalt Chromium Everolimus-Eluting stent), and ...

Abbott also supplies a private-label version of XIENCE V to Boston Scientific called the PROMUS(R) Everolimus-Eluting Coronary Stent System. PROMUS is designed and manufactured by Abbott and ...

Outcomes will compare the PROMUS Element™ Everolimus-Eluting Platinum Chromium Coronary Stent System to the PROMUS® (XIENCE V®) Everolimus-Eluting Coronary Stent System and the ION™ Paclitaxel-Eluting ...

The PLATINUM Workhorse Trial compared the PROMUS Element™ Stent (Platinum Chromium Everolimus-Eluting stent) to the Xience V™ Stent (Cobalt Chromium Everolimus-Eluting stent), and demonstrated ...